Skip to content

KLRS KLRS Total Current Assets

Total Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$54.84B+32.9%
Merck & Co. logo
Merck & Co.MRK
$35.02B-1.4%
Amgen logo
AmgenAMGN
$31.48B+16.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$18.21B+3.6%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$249.5M-23.7%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$706M+82.1%

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Reported directly by KLRS in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's total current assets?
KLRS (KLRS) reported total current assets of $98.47M in Q1 2026.
How has KLRS's total current assets changed year-over-year?
KLRS's total current assets decreased by 3.6% year-over-year, from $102.18M to $98.47M.
What is the long-term trend for KLRS's total current assets?
Over 4 years (2021 to 2025), KLRS's total current assets has grown at a -17.2% compound annual growth rate (CAGR), from $253.35M to $118.81M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.